Streetbeat News

ACGN

Aceragen Inc

http://www.iderapharma.com/

CEO

Vincent Milano

Industry

Biological Product (except Diagnostic) Manufacturing

idera pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. idera is focused on harnessing the potential of our proprietary technology to treat genetically defined forms of b-cell lymphomas and rare autoimmune diseases.

Open

0.43

Mkt cap

3.2M

Volume

53K

High

0.38

P/E Ratio

-0.04

52-wk high

16.00

Low

0.38

Div yield

N/A

52-wk low

0.36

In Wednesday's after-market session, several health care stocks saw significant movement. Gainers included Lixte Biotech Hldgs (LIXT), Align Tech (ALGN), Mallinckrodt (MNK), AIM ImmunoTech (AIM), Celularity (CELU), and Intensity Therapeutics (INTS). Losers included Aceragen (ACGN), Infinity Pharmaceuticals (INFI), Edwards Lifesciences (EW), Plus Therapeutics (PSTV), icad (ICAD), and Bellerophon Therapeutics (BLPH).

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 9:32 pm

The article lists the stocks that gained and lost the most in Wednesday's mid-day session. Some of the top gainers include Silicon Motion Technology Corporation, Mallinckrodt plc, and ABVC BioPharma, Inc. due to various reasons such as merger approvals, potential bankruptcy plans, and new partnerships. On the other hand, some of the top losers include Dunxin Financial Holdings Limited, Carmell Therapeutics Corporation, and Inpixon due to reasons such as weak quarterly sales, pricing of registered direct offering, and merger agreements.

Portfolio Pulse from Lisa Levin

July 26, 2023 | 5:57 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Mallinckrodt (MNK), SCWorx (WORX), Armata Pharmaceuticals (ARMP), Teladoc Health (TDOC), Vincerx Pharma (VINC), and Aceragen (ACGN) saw their stocks rise, with Mallinckrodt leading the gainers with a 60.7% increase. On the other hand, Sage Therapeutics (SAGE), 180 Life Sciences (ATNF), Athersys (ATHX), Etao International Co (ETAO), Inozyme Pharma (INZY), and PaxMedica (PXMD) saw their stocks fall, with Sage Therapeutics leading the losers with a 13.8% decrease.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 5:31 pm

On Wednesday, 59 companies hit new 52-week lows. The largest company by market cap to hit a new low was TC Energy (NYSE:TRP), while the smallest was China SXT Pharmaceuticals (NASDAQ:SXTC). AppHarvest (NASDAQ:APPH)'s stock fell the most, down 19.83%, while XOMA (NASDAQ:XOMA)'s stock bounced back, moving up 0.0% after hitting a new low.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 4:18 pm

On Tuesday, 56 companies hit new 52-week lows. The largest company by market cap to set a new low was Apellis Pharmaceuticals, while the smallest was 9 Meters Biopharma. Humanigen's stock came under the most pressure, trading down 73.22%. NeuBase Therapeutics saw the biggest bounce back, with shares trading up 0.0% after hitting its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 4:33 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. Quoin Pharmaceuticals, Fresh Tracks Therapeutics, LifeMD, Biodexa Pharmaceuticals, bluebird bio, and Fortress Biotech saw their stocks rise by 36.1%, 33.54%, 26.34%, 23.71%, 18.8%, and 15.92% respectively. On the other hand, Redhill Biopharma, Mallinckrodt, Aceragen, BioSig Technologies, Avinger, and Novan saw their stocks decline by 23.8%, 16.21%, 15.08%, 14.34%, 14.29%, and 13.52% respectively.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 5:31 pm

On Friday, 54 companies hit new 52-week lows. The largest company in terms of market cap to set a new 52-week low was NovoCure (NASDAQ:NVCR), while the smallest was Ucommune International (NASDAQ:UK). Sigma Additive Solutions (NASDAQ:SASI) saw the largest move, with shares plummeting 27.56%. Greenbrook TMS (NASDAQ:GBNH) shares were the most resilient, moving up 0.0% in response to hitting its 52-week low.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 5:24 pm

Several stocks experienced significant movement in Friday's mid-day session. Notable gainers include Digital World Acquisition Corp. (DWAC), which jumped 69% after reaching a settlement with the SEC, and ServisFirst Bancshares, Inc. (SFBS), which rose 17.3% following positive Q2 results. On the other hand, Sigma Additive Solutions, Inc. (SASI) fell 34.6%, and Metropolitan Bank Holding Corp. (MCB) dipped 9.3% following weak quarterly results.

Portfolio Pulse from Lisa Levin

July 21, 2023 | 5:01 pm

During Thursday's session, 40 stocks hit new 52-week lows. The largest company by market cap to set a new 52-week low was Crown Castle (NYSE:CCI), while the smallest was Ucommune International (NASDAQ:UK). Vir Biotechnology (NASDAQ:VIR)'s stock fell the most, down 44.38%, while Yunji (NASDAQ:YJ)'s stock rebounded the most, trading up 0.0% after dropping to a new 52-week low.

Portfolio Pulse from Benzinga Insights

July 20, 2023 | 6:01 pm

Aceragen has received a Nasdaq notice regarding a delayed Form 10-Q filing, which may impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 8:27 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.